Gm. Toney et al., Acute and subacute physiological and histological studies of the central nervous system after intrathecal gadolinium injection in the anesthetized rat, INV RADIOL, 36(1), 2001, pp. 33-40
Citations number
16
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
RATIONALE AND OBJECTIVES. TO determine the acute physiological and subacute
neurohistological effects of gadopentetate dimeglumine (GdD) administered
intrathecally,
METHODS. Twenty-four rats were separated into two study groups. In the firs
t group, the acute effects of intrathecal GdD on cortical electroencephalog
raphic activity, renal sympathetic nerve activity, arterial blood pressure,
and heart rate were determined. In the second group, histological evaluati
on of the neural tissues was performed 10 days after treatment. In both the
physiological and histological studies, a single GdD dose of 2.5 mu mol/g
brain (10 muL) was administered intrathecally, Control animals were injecte
d intrathecally with the same volume of a sucrose solution that had the sam
e osmolality as GdD,
RESULTS. In the physiological study, GdD and sucrose injections elicited no
significant change in any of the parameters recorded. In the histologic st
udy, examination revealed two cases of pre-existing chronic spinal cord gli
osis; one of these rats also exhibited signs of pre-existing chronic choroi
d plexus inflammation. No acute or subacute alterations observed could be s
pecifically linked to the intrathecal administration of GdD,
CONCLUSIONS. Intrathecally administered GdD was accompanied by no significa
nt change in any of the physiologic or histologic parameters examined. Base
d on the relatively short time interval between GdD treatment and histologi
c examination, the neural tissue abnormalities (gliosis/inflammation) obser
ved in two animals were judged to be incidental and likely due to prior chr
onic pre-existing processes such as viral infection. Although additional st
udies are required to verify the safety and effectiveness of intrathecal Gd
D in humans, data from the present study in animals provide evidence that w
hen intrathecal GdD is used in doses sufficient to improve MRI of the cereb
rospinal fluid compartment, it is likely to be accompanied by a low inciden
ce of acute changes in neural function or structure.